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Abstract
The aim of this study was to determine the seropositivity of Hepatitis B virus (HBV) and Hepatitis
C virus (HCV) dual infection among blood donors in Nyala Teaching Hospital, which is the biggest
(400 beds) hospital in great Dar Fur of Western Sudan. 400 blood donors were tested serologically
for the detection of HBsAg and anti-HCV antibodies. Only one (0.25%) out of the 400 examined
blood donors was detected reactive for both HBsAg and anti-HCV antibodies. The study
concluded that the seropositivity of HBV and HCV dual infection among population studied is
uncommon.
Introduction
Dual infection with HBV and HCV leads to more aggres-
sive liver disease [1]. In addition to chronic liver disease,
coinfection of HBV and HCV is frequently found in injec-
tion drug users (IDU, 42.5%) [2], patients on hemodialy-
sis (3.7%) [3], patients undergoing organ transplantation
(8%) [4], HIV-positive individuals (66%) [5], and beta-
thalassemia patients (10%) [6], which means that those
are the high risk population for infection of HBV and HCV
concurrently. As HBV and HCV have the same transmis-
sion routes, dual infection may occur [7]. No published
data of the seropostivity of HBV and HCV dual infection
in great Dar Fur, and may be in the large Sudan. So the
current study amied to determine the seropositivity of
HBV and HCV dual infection among blood donors in
Nyala Teaching Hospital.
Materials and methods
This study was conducted during the period from May to
July 2007, in Nyala Teaching Hospital, which is the big-
gest (400 beds) hospital in great Dar Fur, and according to
the blood bank records 3600 pints of blood are collected
annually from blood donors. 400 male, apparently
healthy blood donors were randomly selected and
enrolled in this study. Five ml of blood were drawn from
each subject; sera were separated, aliquoted, labeled
within two hours of collection and stored at -70°C. Serum
samples initially tested for HBsAg and anti-HCV antibod-
ies with Immunochromatographic Test (ICT) from
Advanced Quality, then screened with a 3rd generation
Enzyme Linked Immunosorbent Assay (ELISA), Equi-
HBsAg and EIAgen anti-HCV antibodies from Equibar
and Adalits respectively.
Published: 22 December 2009
Virology Journal 2009, 6:227 doi:10.1186/1743-422X-6-227
Received: 5 November 2009
Accepted: 22 December 2009
This article is available from: http://www.virologyj.com/content/6/1/227
© 2009 Abou and Eltahir; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Virology Journal 2009, 6:227 http://www.virologyj.com/content/6/1/227
Page 2 of 2
(page number not for citation purposes)
Results
A total 400 male blood donors were enrolled in this study,
with a mean age of 33 years and an age range of 18-49
years. The seropositivity of HBV and HCV dual infection
was detected in only one (0.25%) blood donor.
Discussion
Surveillance of carriers of viral hepatitis is essential to
assess the burden of the disease in the population.
Although dual infection with HBV and HCV is not
uncommon in the geographic areas where a high endemic
level of both infections is reported, such as Southeast Asia
and the Mediterranean, the role of this dual infection in
the pathogenesis of chronic liver disease is still controver-
sial (8,9,10,11). Despite dual infection with HBV and
HCV leads to mutual suppression of both viruses, several
studies have suggested that HBV and HCV infection may
be associated with a more severe clinical presentation
[12,13]. The findings of this study showed that the serop-
ositivity of dual infection of HBV and HCV among blood
donors in Nyala Teaching Hospital was (0.25%), this per-
cent is in accordance with the endemic level of both
viruses in South Dar Fur State, Sudan, in which the sero-
prevalence of HBV is of an intermediate level (6.25%) and
HCV seroprevalence of low level (0.65%)[14]. Dual infec-
tion of HBV and HCV in Nyala when compared with stud-
ies conducted in other parts of Sudan, there is afew
published data indicating that dual infection of HBV and
HCV was never detected in Northern Sudan[15]. So dual
infection of HBV and HCV is uncommon in Nyala and
may be in the large Sudan due to the endemic level of
both viruses.
Conclusion
The study concluded that the seropositivity of HBV and
HCV dual infection among population studied is uncom-
mon.
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